Qiagen CEO says working with advisers on strategic review
Source: SeekingAlpha
2026-03-02 15:38:11 ET
More on Qiagen
- Qiagen N.V. (QGEN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Qiagen N.V. (QGEN) Q4 2025 Earnings Call Transcript
- Qiagen N.V. 2025 Q4 - Results - Earnings Call Presentation
- Qiagen targets 9% growth in 2026 growth pillars and $2B by 2028 with new product launches
- Qiagen Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Qiagen CEO says working with advisers on strategic review
Qiagen N.V.
NASDAQ: QGEN
QGEN Trading
-3.03% G/L:
$41.90 Last:
1,050,835 Volume:
$42.64 Open:
QGEN Latest News
March 10, 2026 05:05:00 pm
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
QGEN Stock Data
$10,633,318,293
203,932,295
N/A
22
N/A
Biotechnology & Life Sciences
Healthcare
NL
Venlo
